MLICM
TEVA icon

Metropolitan Life Insurance Company (MetLife)’s Teva Pharmaceuticals TEVA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-43,972
Closed -$620K 1904
2024
Q1
$620K Hold
43,972
0.03% 438
2023
Q4
$459K Hold
43,972
0.02% 477
2023
Q3
$449K Sell
43,972
-2,900
-6% -$29.6K 0.02% 462
2023
Q2
$353K Hold
46,872
0.02% 515
2023
Q1
$415K Sell
46,872
-6,200
-12% -$54.9K 0.02% 493
2022
Q4
$484K Sell
53,072
-4,400
-8% -$40.1K 0.02% 495
2022
Q3
$464K Hold
57,472
0.02% 497
2022
Q2
$432K Hold
57,472
0.02% 518
2022
Q1
$540K Buy
57,472
+4,300
+8% +$40.4K 0.02% 531
2021
Q4
$426K Hold
53,172
0.01% 1546
2021
Q3
$518K Hold
53,172
0.01% 1438
2021
Q2
$526K Buy
53,172
+4,200
+9% +$41.6K 0.01% 1490
2021
Q1
$565K Hold
48,972
0.01% 1338
2020
Q4
$473K Sell
48,972
-4,400
-8% -$42.5K 0.01% 1390
2020
Q3
$481K Sell
53,372
-3,400
-6% -$30.6K 0.01% 1245
2020
Q2
$700K Buy
56,772
+10,000
+21% +$123K 0.01% 972
2020
Q1
$420K Sell
46,772
-3,800
-8% -$34.1K 0.01% 1155
2019
Q4
$496K Hold
50,572
0.01% 1330
2019
Q3
$348K Buy
50,572
+4,100
+9% +$28.2K 0.01% 1518
2019
Q2
$429K Buy
46,472
+1,900
+4% +$17.5K 0.01% 1402
2019
Q1
$699K Buy
44,572
+14,100
+46% +$221K 0.01% 1096
2018
Q4
$470K Hold
30,472
0.01% 1230
2018
Q3
$656K Hold
30,472
0.01% 1180
2018
Q2
$741K Buy
30,472
+2,100
+7% +$51.1K 0.01% 1075
2018
Q1
$485K Sell
28,372
-3,300
-10% -$56.4K 0.01% 1295
2017
Q4
$600K Sell
31,672
-70,453
-69% -$1.33M 0.01% 1160
2017
Q3
$1.8M Buy
102,125
+2,700
+3% +$47.5K 0.01% 972
2017
Q2
$3.3M Sell
99,425
-7,700
-7% -$256K 0.02% 784
2017
Q1
$3.44M Sell
107,125
-2,000
-2% -$64.2K 0.02% 769
2016
Q4
$7.64M Buy
+109,125
New +$7.64M 0.05% 337